The incubation of tumor cells with splenic T cells derived from B16F10-bearing mice treated with the local CAER led to the activation of a greater number of tumor antigen-specific CD4+ T cells and CD8+ T cells than that with T cells in the other treatment groups (Figures 5C, D). This evidence concerns the gene CD4 and neoplasm.